Xylem Inc risk profile
31 Normal where most of the sector sits
Measured 1 September 2026 from XYL's filed statements. Recomputed nightly.
31 (Normal), driven by Competitive position at 38, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 35 | Normal | Stable | Drawdown from the 52-week high — 27.2% |
| Operating pressure | 29 | Normal | Stable | Costs outgrowing revenue — -2.6 percentage points |
| Cash conversion | 32 | Normal | Worsening | Cash conversion — 1.30x |
| Leverage and coverage | 11 | Contained | Stable | Current ratio — 1.63x |
| Competitive position | 38 | Normal | Stable | Operating-margin gap against peers — +0.9 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.